FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4296643503> ?p ?o ?g. }

• W4296643503 endingPage "311" @default.
• W4296643503 startingPage "301" @default.
• W4296643503 abstract "Hypercoagulability and hypofibrinolysis in acutely decompensated cirrhosis (AD) may be implicated in disease progression and haemostatic complications. We conducted a prospective study to: (1) characterise haemostatic alterations in AD; (2) evaluate whether such alterations can predict acute-on-chronic liver failure (ACLF) and bleeding/thrombosis.Hospitalised individuals with AD were prospectively recruited and underwent an extensive haemostatic profiling including coagulation factors, thrombomodulin-modified thrombin generation assay with evaluation of endogenous thrombin potential (ETP; marker for plasmatic hypercoagulability), fibrinolytic factors, and plasmin-antiplasmin complex (fibrinolysis activation marker). Inflammation severity was assessed by C-reactive protein (CRP). In part 1 of the study, we compared haemostasis in AD vs. controls (stable decompensated and compensated cirrhosis). In part 2 of the study, we prospectively followed individuals with AD for 1 year and investigated predictors of ACLF and bleeding/thrombosis.A total of 169 individuals with AD were recruited (median model for end-stage liver disease score 20; CLIF-C AD 54). Compared with controls, AD was associated with more pronounced hypercoagulability (ETP: 871 vs. 750 vs. 605 nmol/L per min; p <0.0001), without differences in fibrinolysis activation. During follow-up, 55 individuals developed ACLF. CLIF-C AD, CRP, and Child-Pugh were independently associated with ACLF. A predictive model combining these variables (Padua model) accurately identified individuals at higher risk of ACLF (AUROC 0.857; 95% CI 0.798-0.915; sensitivity 74.5%, specificity 83.3%). Notably, CRP and progression to ACLF, but not baseline coagulopathy, were associated with bleeding (n = 11); CRP and antifibrinolytic factor PAI-1 >50 ng/ml were associated with thrombosis (n = 14). The prognostic value of the Padua model was validated in an independent, bicentric European cohort (N = 301).Inflammation severity, and not coagulopathy, is the most important predictor of ACLF and bleeding in AD. The Padua model can be used to identify individuals with AD at risk of ACLF.A better understanding of haemostasis in individuals with acutely decompensated cirrhosis may help to identify those at higher risk of progression and complications. In this prospective study, we found no significant association between alterations of haemostasis and cirrhosis progression, indicating that the assessment of haemostatic alterations is not useful to identify those at risk. However, we found that C-reactive protein (a simple blood test that reflects severity of inflammation) and severity of chronic liver disease itself (as assessed by specific scores) were associated with cirrhosis progression and development of bleeding complications. Therefore, we developed a simple predictive model - based on C-reactive protein and liver disease scores - that, if validated by independent studies, could be used in clinical practice to assist physicians in identifying individuals with decompensated cirrhosis at higher risk of disease progression and death (i.e. in whom to consider an expedited evaluation for liver transplantation)." @default.
• W4296643503 created "2022-09-23" @default.
• W4296643503 creator A5001144757 @default.
• W4296643503 creator A5010777746 @default.
• W4296643503 creator A5019017450 @default.
• W4296643503 creator A5020587343 @default.
• W4296643503 creator A5020674188 @default.
• W4296643503 creator A5027631947 @default.
• W4296643503 creator A5029282864 @default.
• W4296643503 creator A5031677659 @default.
• W4296643503 creator A5032961667 @default.
• W4296643503 creator A5035345356 @default.
• W4296643503 creator A5045504446 @default.
• W4296643503 creator A5065572516 @default.
• W4296643503 creator A5087316703 @default.
• W4296643503 creator A5087412260 @default.
• W4296643503 creator A5088041819 @default.
• W4296643503 creator A5090751499 @default.
• W4296643503 date "2023-02-01" @default.
• W4296643503 modified "2023-10-14" @default.
• W4296643503 title "Severity of systemic inflammation is the main predictor of ACLF and bleeding in individuals with acutely decompensated cirrhosis" @default.
• W4296643503 cites W2007670274 @default.
• W4296643503 cites W2010275186 @default.
• W4296643503 cites W2135617792 @default.
• W4296643503 cites W2344515048 @default.
• W4296643503 cites W2418438757 @default.
• W4296643503 cites W2747912680 @default.
• W4296643503 cites W2801699702 @default.
• W4296643503 cites W2802906787 @default.
• W4296643503 cites W2971304637 @default.
• W4296643503 cites W2989714602 @default.
• W4296643503 cites W3003329520 @default.
• W4296643503 cites W3040316445 @default.
• W4296643503 cites W3043538464 @default.
• W4296643503 cites W3081186914 @default.
• W4296643503 cites W3090683244 @default.
• W4296643503 cites W3093189997 @default.
• W4296643503 cites W3098683226 @default.
• W4296643503 cites W3111137164 @default.
• W4296643503 cites W3117369512 @default.
• W4296643503 cites W3134478127 @default.
• W4296643503 cites W3157388465 @default.
• W4296643503 cites W3164716322 @default.
• W4296643503 cites W3165395408 @default.
• W4296643503 cites W3181293256 @default.
• W4296643503 cites W3194057546 @default.
• W4296643503 cites W3207318727 @default.
• W4296643503 cites W4200473175 @default.
• W4296643503 cites W4206378166 @default.
• W4296643503 cites W4210584037 @default.
• W4296643503 cites W4220780901 @default.
• W4296643503 cites W4220963560 @default.
• W4296643503 cites W4224216090 @default.
• W4296643503 cites W4281670983 @default.
• W4296643503 doi "https://doi.org/10.1016/j.jhep.2022.09.005" @default.
• W4296643503 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36150575" @default.
• W4296643503 hasPublicationYear "2023" @default.
• W4296643503 type Work @default.
• W4296643503 citedByCount "16" @default.
• W4296643503 countsByYear W42966435032022 @default.
• W4296643503 countsByYear W42966435032023 @default.
• W4296643503 crossrefType "journal-article" @default.
• W4296643503 hasAuthorship W4296643503A5001144757 @default.
• W4296643503 hasAuthorship W4296643503A5010777746 @default.
• W4296643503 hasAuthorship W4296643503A5019017450 @default.
• W4296643503 hasAuthorship W4296643503A5020587343 @default.
• W4296643503 hasAuthorship W4296643503A5020674188 @default.
• W4296643503 hasAuthorship W4296643503A5027631947 @default.
• W4296643503 hasAuthorship W4296643503A5029282864 @default.
• W4296643503 hasAuthorship W4296643503A5031677659 @default.
• W4296643503 hasAuthorship W4296643503A5032961667 @default.
• W4296643503 hasAuthorship W4296643503A5035345356 @default.
• W4296643503 hasAuthorship W4296643503A5045504446 @default.
• W4296643503 hasAuthorship W4296643503A5065572516 @default.
• W4296643503 hasAuthorship W4296643503A5087316703 @default.
• W4296643503 hasAuthorship W4296643503A5087412260 @default.
• W4296643503 hasAuthorship W4296643503A5088041819 @default.
• W4296643503 hasAuthorship W4296643503A5090751499 @default.
• W4296643503 hasConcept C126322002 @default.
• W4296643503 hasConcept C141071460 @default.
• W4296643503 hasConcept C188816634 @default.
• W4296643503 hasConcept C203014093 @default.
• W4296643503 hasConcept C2776252253 @default.
• W4296643503 hasConcept C2776825266 @default.
• W4296643503 hasConcept C2776914184 @default.
• W4296643503 hasConcept C2777214474 @default.
• W4296643503 hasConcept C2778382381 @default.
• W4296643503 hasConcept C2778589496 @default.
• W4296643503 hasConcept C2779250428 @default.
• W4296643503 hasConcept C2779609443 @default.
• W4296643503 hasConcept C2779637338 @default.
• W4296643503 hasConcept C2779936836 @default.
• W4296643503 hasConcept C2780868729 @default.
• W4296643503 hasConcept C2781195455 @default.
• W4296643503 hasConcept C2781219028 @default.
• W4296643503 hasConcept C2781436528 @default.
• W4296643503 hasConcept C2911091166 @default.
• W4296643503 hasConcept C2991743468 @default.

• next